URGN — Urogen Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Annual balance sheet for Urogen Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	102	89.1	100	137	237
Net Total Accounts Receivable
Net Total Receivables	7.05	11.7	12.7	15.4	20.3
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	116	114	129	169	276
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4.2	3.15	3.75	2.36	3.79
Long Term Investments
Other Long Term Assets
Total Assets	122	120	136	178	286
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	21.4	22.4	23.9	31.2	45.9
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	25.6	111	225	244	295
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	96.4	8.41	-89.4	-65.2	-8.8
Total Liabilities & Shareholders' Equity	122	120	136	178	286
Total Common Shares Outstanding